Webinars: live and on demand

Influenza & COVID-19: Preparing for the 2020-2021 Flu Season

Wednesday, August 26, 2020 12 p.m. to 12:40 p.m. EDT

COVID-19 has forcefully reminded people of their vulnerability to infectious diseases. As influenza season approaches, your patients face a potential double threat to their health. More than ever, vaccination against influenza is an essential preventative measure, particularly for at-risk groups such as adults aged 65 and older.

Join Dr. Angel Chu, infectious diseases specialist, Foothills Medical Centre in Calgary, Alberta, and Vice-Chair of Immunize Canada to better understand the interplay between influenza and COVID-19. We will also:

      • Review the burden of influenza and at-risk groups
      • Discuss how to optimize influenza vaccinations for high-risk populations
      • Share practical tips and tools for maintaining immunizations in light of COVID-19

You will be able to submit questions during this live, online session. There is no cost to participate.

This program is an unaccredited learning activity supported by Sanofi Pasteur.


Webinars on demand

The New Cell-Based Influenza Vaccine: Implications for Your Patients

A new influenza vaccine will be available in Canada for the 2020-21 flu season. As the first cell-based vaccine, its ability to accommodate antigenic drift represents an important advance in vaccine effectiveness, particularly for patients who are at high risk of disability or death due to influenza. Learn what you need to know about this new vaccine option in this accredited webinar, led by community pharmacist and researcher John Papastergiou.

NOTE: On on-demand version of this webinar, approved for 1.0 CE unit by the Canadian Council on Continuing Education in Pharmacy, is available on eCortex.ca. Click here.


Poop talk to pep talk: Effective probiotics for GI patients

Functional GI disorders create a host of issues, such as bloating, abdominal pain and discomfort, as well as unpredictable issues with bowel movements that can limit a person’s ability to participate in most daily activities. During these stressful pandemic times, your patients are particularly prone to frequent and intense GI symptoms that can impact their health and quality of life. But there are readily available and effective interventions out there. Evidence shows that the right probiotic can make all the difference in improving GI symptoms for your patients.

Dragana Skokovic-Sunjic, a clinical pharmacist and leader in probiotic education in North America, discusses effective probiotics and how you can guide your patients in finding a tailored GI treatment.

After watching this webinar, pharmacists will be able to:

  • Confidently interact with patients suffering from functional gastrointestinal problems
  • Understand the mechanism of action and the role of probiotics in the treatment of common GI conditions
  • Get the knowledge and skills to educate and guide patients in selecting the most appropriate probiotic intervention

This program is an unaccredited learning activity, supported by P&G.

Click here to view.


‘Digesting’ the human microbiome: its role and enablers in infants and children

Based on decades of scientific research, we have a better understanding of the role of a balanced intestinal microbiota composition in health and disease. In early life especially, the composition of the microbiota profoundly influences the development and maturation of the gastrointestinal tract mucosa.

Dr. Jose Garza, pediatric neurogastroenterologist, and Dragana Skokovic-Sunjic, clinical pharmacist, join for an interactive webinar in which they:

          • Explore the composition and role of the human microbiome, and understand factors that negatively impact its composition
          • Review microbiome enablers and the use of probiotics for the modulation of a healthy microbiota composition
          • Examine real-world evidence involving pediatric patients with functional gastrointestinal disorders, and the outcomes following the use of evidence-based probiotics
          • Learn how to select and integrate probiotics into your practice, and how to counsel parents of children with functional gastrointestinal disorders

Presented by CandianHealthcareNetwork.ca and the Medical Post. This free program is an unaccredited learning activity, supported by Ferring Canada.

Click here to watch now, and order samples of BioGaia pediatric products and patient counselling tools:

Physicians click here.

Pharmacists click here.


Innovations in Cancer Treatment

CAR-T Therapy for Hematologic Malignancies

Chimeric antigen receptor (CAR)-T cell therapy is a promising new treatment for blood cancers. It is an individualized therapy that harnesses the power of the immune system by genetically modifying cells to enable them to kill cancer. Dr. Mustaqeem Siddiqui, a hematologist oncologist with extensive expertise in CAR-T cell therapy, discusses:

          • how T cells are engineered in a laboratory to make a new protein called a chimeric antigen receptor (CAR), which enables a T cell to recognize a cancer cell that expresses the antigen.
          • the current active clinical trials to examine the use of CAR-T cell therapy earlier in the management of leukemia, lymphoma, and multiple myeloma.
          • the most recent results of FDA-approved uses for CAR-T cell therapy and the optimal time to consider such therapy for patients.

Proton Beam Therapy for Fewer Potential Complications

Radiation oncologist Dr. Anita Mahajan discusses how proton beam therapy helps patients survive their cancers with potentially fewer severe side effects and complications – a benefit that is especially impactful for children with cancer. Gain expertise on how proton beam therapy can be optimized to help your patients battling cancer. Also:

          • Review the latest innovations for treating patients who previously received radiation therapy.
          • Examine how proton beam therapy precisely targets protons to tumours while sparing more healthy tissue and organs.
          • Explore the different types of cancers that benefit most from proton beam treatment.
          • You will be able to submit your own questions during this live session.

Physicians click here to view.

Pharmacists click here to view.

Medical Cannabis: Risks, Myths and Misconceptions

This webinar addresses patients’ and physicians’ most common fears and beliefs about medical cannabis. Dr. Lionel Marks de Chabris, a pain and addiction specialist, has included medical cannabis as a treatment option for patients since 2007. Here he shares his knowledge of this treatment option with respect to many of the common concerns of physicians and patients, with a focus on patient counselling and education.

Topics addressed include:

          • Adverse effects
          • Intoxication and overdose
          • Risk of accidental exposure
          • Psychosis
          • Myocardial infarction
          • Cancer
          • Cannabis use disorder
          • Amotivational syndrome
          • Cannabis hyperemesis syndrome
          • Impaired cognition
          • Withdrawal

Click here to view.

Webinar: Asthma & COPD: Medical Devices that will Change your Practice

Improving patient outcomes for respiratory patients may be as simple as adding on a medical device to their treatment plan. Healthcare professionals often overlook prescribing and recommending medical devices, which can be an effective way to deliver medication and help drug deposition in the lungs. In this on-demand video, Dr. Alan Kaplan, a family physician with extensive expertise in respiratory care, reviews the latest updates on managing your COPD and asthma patients, examines real-world evidence on patient outcomes with respiratory devices and how they make a difference, offers tips on how to use medical devices in your practice and for talking to patients about device reimbursement.

Pharmacists, click here to view.

Physicians, click here to view.

Enhancing Flu-ency for Your 65+ Patients

In this webinar, Dr. Brian Aw, pharmacist Umberto Leone and Dr. David Colby explore the overlooked burden of influenza that extends beyond the lung, and why influenza can be considered a cardiorespiratory disease among older adults. They also examine the clinical evidence for immunization against influenza among adults 65 and older, including a review of new recommendations from the updated 2018-19 National Advisory Committee on Immunization; and provide an overview of publicly funded influenza immunization programs for older adults, including updates on the availability of the high-dose influenza vaccine in your province.

Pharmacists, click here to view.

Physicians, click here to view.

Our mission statement: To be the one-of-a-kind online destination for healthcare professionals, where they will learn, engage and grow individually and inter-professionally to advance better health for all Canadians.
Copyright 2009-2020 EnsembleIQ. All rights reserved.